Company intelligence / Profile preview

Lilial

Saint-Barthélemy-d'Anjou, France

Ownership: Private
Employees: ~90
Development stage: Other

Overview

Lilial is a French healthcare services company that provides direct-to-consumer home delivery of reimbursed medical devices and supplies. The company focuses primarily on urology, ostomy and wound or scar care products, supplying patients across France and coordinating with healthcare professionals. Rather than operating as a drug developer, Lilial functions as a commercial medical distribution and patient-service business. The company was founded in 2003 and was acquired by Coloplast in December 2017 for EUR 35.5 million, after which it continued operating as a Coloplast subsidiary in France.

Therapeutic areas: NephrologyDermatologyGastroenterology
Modalities: Device
Industry: Non-Academic Healthcare

Partnerships

Coloplast

Beyond the preview

Go deeper on Lilial.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lilial.

Explore the full profile